Clinical Consequences and Novel Therapy of Hyperphosphatemia: Lanthanum Carbonate for Dialysis Patients

Publisher： Bentham Science Publishers

E-ISSN： 2212-3962|2|1|29-34

ISSN： 1574-8901

Source： Recent Patents on Cardiovascular Drug Discovery, Vol.2, Iss.1, 2007-01, pp. : 29-34

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Hyperphosphatemia on Cardiovascular Disease in Dialysis Patients

By  

Vascular Disease Prevention, Vol. 3, Iss. 2, 2006-05 ,pp. : 123-128

Bentham Science Publishers

Access to resources Recommend Favorite

Arterial Stiffening and Clinical Outcomes in Dialysis Patients

By  

Pulse, Vol. 3, Iss. 2, 2015-05 ,pp. : 89-97

Karger

Access to resources Recommend Favorite

Does Parathyroid Hormone Affect Erythropoietin Therapy in Dialysis Patients?

By  

Medical Principles and Practice, Vol. 16, Iss. 1, 2006-12 ,pp. : 63-67

Karger

Access to resources Recommend Favorite

Arterial Accelerated Aging in Dialysis Patients: The Clinical Impact of Vascular Calcification

By  

Current Vascular Pharmacology, Vol. 7, Iss. 3, 2009-07 ,pp. : 374-380

Bentham Science Publishers

Access to resources Recommend Favorite

The Use of Lithium Carbonate in the Preparation for Definitive Therapy in Hyperthyroid Patients

By  

Medical Principles and Practice, Vol. 17, Iss. 2, 2008-02 ,pp. : 167-170

Karger

Access to resources Recommend Favorite